Trends in the prescription of systemic anticancer therapy and mortality among patients with advanced non-small cell lung cancer: a real-world retrospective observational cohort study from the I-O optimise initiative.

导出 OA

翻译打印收藏纠错

第一作者： Michael,Snee

第一单位： Leeds Teaching Hospitals NHS Trust, Leeds, UK m.snee@nhs.net.

作者： Michael,Snee ^[1] ; Sue,Cheeseman ^[2] ; Matthew,Thompson ^[2] ; Majid,Riaz ^[3] ; Will,Sopwith ^[2] ; Laure,Lacoin ^[3] ; Carlos,Chaib ^[2] ; Melinda,Manley Daumont ^[3] ; John R,Penrod ^[4] ; John C,O'Donnell ^[5] ; Geoff,Hall ^[6]

作者单位： Leeds Teaching Hospitals NHS Trust, Leeds, UK m.snee@nhs.net. ^[1] Leeds Teaching Hospitals NHS Trust, Leeds, UK. ^[2] Real-World Insights, IQVIA, London, UK. ^[3] Epi-Fit, Bordeaux, Nouvelle-Aquitaine, France. ^[4] R&D Medical Affairs, Bristol Myers Squibb, Madrid, Spain. ^[5] Worldwide Health Economics & Outcomes Research, Bristol Myers Squibb, Braine-l'Alleud, Belgium. ^[6] Worldwide Health Economics & Outcomes Research, Bristol Myers Squibb, Princeton, New Jersey, USA. ^[7] Leeds Institute for Data Analytics, University of Leeds, Leeds, UK. ^[8]

关键词 chemotherapy epidemiology oncology respiratory tract tumours thoracic medicine

主题词成年人(Adult);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);人类(Humans);肺肿瘤(Lung Neoplasms);处方(Prescriptions);回顾性研究(Retrospective Studies);公费医疗(State Medicine)

DOI 10.1136/bmjopen-2020-043442

PMID 33941627

发布时间 2021-06-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交